Presume a couple found out their embryo has a gene mutation that has a high success...

Presume a couple found out their embryo has a gene mutation that has a high success rate of causing cancer later on in the baby’s life.

Would you advocate the use of gene therapy in the embryo to correct the problem before the child was ever born? What if the embryo did not appear likely to develop a genetic disease, but the parents decided that they would really prefer that their child have blue eyes as opposed to brown? Would you advocate the use of gene therapy in this case? Should the use of this therapy be limited? Who should decide those limits?

Solutions

Expert Solution

Gene therapy is an advanced high-risk genetic engineering procedure. This has been performed in past to cure SCID, but it is highly risky and success is not guaranteed. In the given case, the mere presence of the gene which might cause cancer cannot justify the gene therapy. The cancer is not a disease, but malfunctioning of regular genes and proteins. These mutations many times do not show up and many people with the mutant allele which might cause cancer have lived healthy through their life. The gene therapy certainly cannot be done if the parents want a blue-eyed baby and not a brown. This is not ethical and we cannot allow people to have what is called "designer babies". This might result in baby race war where all parents want good looking, intelligent child. this will elevate the socio-economical problems in society and we might end up having clones and designs instead of natural babies with diversified characters.
The therapy must be limited to rare and lethal disease only. it cannot be a part of general medicine. Only parents can take this call and they must be responsible when they make decisions.

gladiator answered 1 year ago

Next > < Previous

Related Solutions

If an embryo had knock-out mutations in both a gap gene and a segment polarity gene,...

If an embryo had knock-out mutations in both a gap gene and a segment polarity gene, determine which mutant phenotype you would expect to see. Explain your reasoning?

A. A mutation in the Dorsal gene that causes the Dorsal protein to bind with high...

A. A mutation in the Dorsal gene that causes the Dorsal protein to bind with high affinity to all of the DNA binding sites for dorsal (remember normally there are low and high affinity sites in front of different genes that allow the effect of a gradient to proceed at the molecular level). 1)What will happen to the particular molecule, 2) what would happen at the cell(s) level, and 3) what would happen at the level of the whole body...

A spontaneous mutation occurs in one of the copies of MT-TK, a gene found in mitochondrial...

A spontaneous mutation occurs in one of the copies of MT-TK, a gene found in mitochondrial DNA. MT-TK generates a tRNA required to make proteins formitochondrial function. a. How can this mutation become deleterious? b. In which parent and in which cells must this spontaneous mutation occur for it to be inherited? (hint: what happens if the mutation occurs in the heart.)

What is the most common mutation found in the CFTR gene? c. Sickle cell anemia is...

What is the most common mutation found in the CFTR gene? c. Sickle cell anemia is also inherited as an autosomal recessive trait. What gene is mutated to cause sickle cell anemia? (1 pt) d. Why is it advantageous for a person to be heterozygous for the sickle cell trait? (2 pts)

he distribution of the CCR5 mutation is found at high frequency in Northern Europe and at...

he distribution of the CCR5 mutation is found at high frequency in Northern Europe and at progressively lower frequency as we move south. This would be an example of which phenomenon studied in population genetics? A) Gene flow B) Drift C) Natural selection D) Mutation

Consider two genes with different expected mutation rates due to size. Gene 1 has a mutation...

Consider two genes with different expected mutation rates due to size. Gene 1 has a mutation rate of 1 x 10-6 in the population, while gene 2 has a mutation rate of 3 x 10-6 in the population. Assume that the probability for an individual to have two mutations in one gene is 0. Also, the number of bases, n, in a gene is large. State the probability for gene 1 and for gene 2 that there is exactly one...

Consider two genes with different expected mutation rates due to size. Gene 1 has a mutation...

Consider two genes with different expected mutation rates due to size. Gene 1 has a mutation rate of 1 x 10-6 in the population, while gene 2 has a mutation rate of 3 x 10-6 in the population. Assume that the probability for an individual to have two mutations in one gene is 0. Also, the number of bases, n, in a gene is large. State the probability that there are more than two people with mutations total between the...

A patient has a genetic mutation in the gene for glutaminase that significantly reduces the efficiency...

A patient has a genetic mutation in the gene for glutaminase that significantly reduces the efficiency of this enzyme, leading to a decrease in glutamatergic signaling. Which of the following could potentially compensate for this? a. A downregulation of aspartate aminotransferase b. A downregulation of VGLUT c. An upregulation of neuronal glutamate transporters d. An upregulation of VIAAT

7. Individual C has a mutation in the proopiomelanocortin gene (POMC), resulting in the lack of...

7. Individual C has a mutation in the proopiomelanocortin gene (POMC), resulting in the lack of functional alpha-melanocyte stimulating hormone (alpha-MSH). a) How might this mutation impact binding at the MC4 receptor? b) Phenotypically, is individual C likely to be underweight, normal weight, or overweight? Why?

Research has shown that 1 women in 400 carry a mutation of the BRCA gene. About...

Research has shown that 1 women in 400 carry a mutation of the BRCA gene. About 6 out of 10 women with this mutation develop breast cancer. About 1 out of 10 women without this mutation develop breast cancer. (a) Find the probability that a randomly selected woman will carry the mutation of the BRCA gene and will develop breast cancer. Give your answer as a decimal. (b) Are the events “carrying the mutation” and “developing breast cancer” independent? Briefly...

Subjects